SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (11)5/22/2001 4:56:34 PM
From: scaram(o)uche  Read Replies (1) of 1005
 
BLUE HP makes its first move. Buys 2000 shares of AGNT @ $4.80. You guys want therapeutic or genomics
companies in here? Show me the research!


Nice first move!

VGNX was up another 7% today, and has proven to be another nice hellish play. Not a LSBC, but very, very hellish indeed.........

siliconinvestor.com

siliconinvestor.com

With respect to therapeutics or diagnostics components....... we're late on the curve, establishing this portfolio. The maximum leverage for many components was hit was on 16 April, the convergence of a hellish biotech sentiment, a hellish liquidity crunch, a hellish supply of paper, and a hellish desire to pay taxes.

siliconinvestor.com

OK...... it won't meet your criteria for sitting down on cash, as it (1) never made it, and (2) it has recovered some. However, I nominate TELK. Research given in the TELK thread..........

siliconinvestor.com

siliconinvestor.com

And, of course, is anyone going to give an instantaneous "no" to LEXG? I'm not saying that it's a no-brainer, but it's deserving of some consideration..........

siliconinvestor.com

siliconinvestor.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext